EPHA3
Summary: This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
EPH receptor A3 | MIM:179611 | Ensembl:ENSG00000044524 | HGNC:HGNC:3387 | PA27819 | 3p11.1 |
GO terms in EPHA3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IEA | GO:0005576 | extracellular region |
CC | IBA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005769 | early endosome |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0005887 | integral component of plasma membrane |
CC | IDA | GO:0005887 | integral component of plasma membrane |
CC | IBA | GO:0043005 | neuron projection |
CC | IBA | GO:0043235 | receptor complex |
BP | IEA | GO:0007155 | cell adhesion |
BP | IBA | GO:0007275 | multicellular organism development |
BP | IBA | GO:0009968 | negative regulation of signal transduction |
BP | ISS | GO:0010717 | regulation of epithelial to mesenchymal transition |
BP | IMP | GO:0010976 | positive regulation of neuron projection development |
BP | ISS | GO:0016477 | cell migration |
BP | IDA | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | IBA | GO:0030154 | cell differentiation |
BP | IDA | GO:0032956 | regulation of actin cytoskeleton organization |
BP | IBA | GO:0033674 | positive regulation of kinase activity |
BP | IBA | GO:0043066 | negative regulation of apoptotic process |
BP | IDA | GO:0043087 | regulation of GTPase activity |
BP | IBA | GO:0043410 | positive regulation of MAPK cascade |
BP | IDA | GO:0045806 | negative regulation of endocytosis |
BP | IDA | GO:0048013 | ephrin receptor signaling pathway |
BP | TAS | GO:0048013 | ephrin receptor signaling pathway |
BP | IDA | GO:0051893 | regulation of focal adhesion assembly |
BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
BP | IDA | GO:0070507 | regulation of microtubule cytoskeleton organization |
BP | IMP | GO:0071300 | cellular response to retinoic acid |
BP | ISS | GO:0097155 | fasciculation of sensory neuron axon |
BP | ISS | GO:0097156 | fasciculation of motor neuron axon |
BP | IDA | GO:1903078 | positive regulation of protein localization to plasma membrane |
MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
MF | IBA | GO:0004713 | protein tyrosine kinase activity |
MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
MF | IDA | GO:0005004 | GPI-linked ephrin receptor activity |
MF | IBA | GO:0005005 | transmembrane-ephrin receptor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
Gene expression in normal tissue: EPHA3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in EPHA3
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP2882 | Nuclear Receptors Meta-Pathway |
wikipathways | WP2884 | NRF2 pathway |
pid | epha_fwdpathway | EPHA forward signaling |
netpath | Pathway_TCR | TCR |
kegg | hsa04360 | Axon guidance - Homo sapiens (human) |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-2682334 | EPH-Ephrin signaling |
reactome | R-HSA-2682334 | EPH-Ephrin signaling |
reactome | R-HSA-3928663 | EPHA-mediated growth cone collapse |
reactome | R-HSA-3928663 | EPHA-mediated growth cone collapse |
reactome | R-HSA-3928665 | EPH-ephrin mediated repulsion of cells |
reactome | R-HSA-3928665 | EPH-ephrin mediated repulsion of cells |
reactome | R-HSA-422475 | Axon guidance |
reactome | R-HSA-422475 | Axon guidance |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD138 | PX 12 | 3 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD260 | FQI-2 | 6 |
iGMDRD207 | Capsaicin | 2 |
iGMDRD870 | BRD63610 | 3 |
iGMDRD318 | PAC-1 | 3 |
iGMDRD441 | TW 37 | 2 |
iGMDRD398 | Sepantronium | 3 |
iGMDRD506 | Fedratinib | 3 |
iGMDRD64 | Parbendazole | 7 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD444 | Tivantinib | 1 |
iGMDRD23 | Gossypol | 4 |
iGMDRD903 | EPHA3 inhibitor | 2 |
iGMDRD151 | CHM-1 | 9 |
iGMDRD433 | Lexibulin | 2 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD152 | 179324-69-7 | 1 |
iGMDRD193 | Fqi1 | 7 |
iGMDRD61 | Kinetin riboside | 4 |
iGMDRD280 | CYTOCHALASIN B | 8 |
iGMDRD394 | BX-795 | 2 |
iGMDRD202 | Curcumin | 2 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD6 | AM-580 | 2 |
iGMDRD705 | Nakiterpiosin | 7 |
iGMDRD221 | Tamoxifen | 4 |
iGMDRD481 | Dactolisib | 5 |
iGMDRD882 | CIL41 | 2 |
iGMDRD67 | PENFLURIDOL | 2 |
iGMDRD414 | MST-312 | 5 |
iGMDRD662 | JQ-1 | 1 |
iGMDRD329 | Merck60 | 2 |
iGMDRD246 | NPC26 | 2 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD300 | Tozasertib | 1 |
iGMDRD322 | FK 866 | 2 |
iGMDRD82 | Quiflapon | 2 |
iGMDRD307 | Manumycin A | 2 |
iGMDRD84 | Lovastatin acid | 2 |
iGMDRD150 | RITA | 2 |
iGMDRD116 | CD437 | 5 |
iGMDRD583 | LDN 193189 | 1 |
iGMDRD701 | NVP-AUY922 | 6 |
iGMDRD698 | Neratinib | 1 |
iGMDRD123 | Isoevodiamine | 6 |
iGMDRD901 | ELCPK | 5 |
iGMDRD132 | (-)-gallocatechin-3-O-gallate | 2 |
iGMDRD945 | ML214 | 2 |
iGMDRD435 | BI-2536 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in EPHA3